Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Type I+III Oral Poliomyelitis Vaccine (Human Diploid Cell) Phase III Sequential Immunization Study
CTR20160167Phase 3Active
- Sponsor
- Institute of Medical Biology
- Start
- Aug 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bivalent oral poliovirus vaccine types 1 and 3 (human diploid cell) in Poliomyelitis type 1 (PV1), poliomyelitis, sponsored by Institute of Medical Biology. Started Aug 2016; status: active.
02
Drugs
bivalent oral poliovirus vaccine types 1 and 3 (human diploid cell)
03
Conditions
Poliomyelitis type 1 (PV1)poliomyelitis
Beyond the preview
Go deeper on CTR20160167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160167.